# A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement

> **NCT07691307** · NA · RECRUITING · sponsor: **Jiangsu Trulive Medical Co., Ltd** · enrollment: 180 (estimated)

## Conditions studied

- Tricuspid Valve Regurgitation
- Tricuspid Valve Insufficiency
- Tricuspid Valve Disease

## Interventions

- **DEVICE:** TruGamma System
- **DRUG:** Optimal medical therapy (OMT)

## Key facts

- **NCT ID:** NCT07691307
- **Lead sponsor:** Jiangsu Trulive Medical Co., Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-18
- **Primary completion:** 2028-08-30
- **Final completion:** 2028-08-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691307, "A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07691307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*